November 2, 2018 Comments Off on BioMed Realty Inks 479K-SF Biopharma Deal in S. San Francisco Views: 1331 California News, Top California

BioMed Realty Inks 479K-SF Biopharma Deal in S. San Francisco

San Diego-based BioMed Realty signed a 479,000-square-foot lease with AbbVie at Gateway of Pacific in South San Francisco. The Chicago-based global biopharmaceutical company is taking space in the initial phase of the development, which consists of 500,000 square feet of office and laboratory space and a 50,000-square-foot amenity center.

Work on BioMed’s fully-integrated 1.3-million-square-foot “Science in a Park” campus on Gateway Boulevard commenced last year. Once complete, it will feature dedicated outdoor environments, punctuated by Gateway Central Park in the middle of the campus, which includes:

– Indoor and outdoor collaboration hubs
– Diverse sports and recreation venues
– Outdoor dining plaza
– Fire pits and lounge
– BBQ and picnic areas
– Food truck docks
– Zen garden

AbbVie works in four primary therapeutic areas: immunology, oncology, virology and neuroscience. The company has 30,000 employees, including more than 8,000 in R&D roles, and generated revenue of $28.2 billion in 2017. It operates eight R&D centers, including one in South San Francisco, another in Redwood City, CA and one in Sunnyvale, CA.

Connect With BioMed Realty


Get CRE News in 150 words

For comments, questions or concerns, please contact Dennis Kaiser

Tags: ,

Comments are closed.